APA (7th ed.) Citation

NA, M., W, S., L, G., L, K., J, J., A, B., . . . D, v. D. (2026). Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 83(1), e27. https://doi.org/10.1093/cid/ciag160

Chicago Style (17th ed.) Citation

NA, Mackow, et al. "Escherichia Coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 83, no. 1 (2026): e27. https://doi.org/10.1093/cid/ciag160.

MLA (9th ed.) Citation

NA, Mackow, et al. "Escherichia Coli ST131 Drives Carbapenem Use for E. Coli Bloodstream Infections." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 83, no. 1, 2026, p. e27, https://doi.org/10.1093/cid/ciag160.